Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients
Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The aim of this phase I/II trial is to determine the dose of daunorubicine to be associated
with cytarabine and Imatinib for induction therapy in patients with chronic myelogenous
leukemia in myeloid acute phase.